The clinical significance of diffuse thyroid uptake that is incidentally identified by F-18 FDG PET/CT imaging in patients with breast cancer

Journal of Breast Cancer

Volumn 12, Issue 4, 2009, Pages 309-315

  Jeong, Young Jin ^a   Lim, Seok Tae ^a   Kim, Dong Wook ^a   Jeong, Hwan Jeong ^a   Youn, Hyun Jo ^a   Jung, Sung Hoo ^a   Sohn, Myung Hee ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Breast; Carcinoma; Diffuse; F 18 FDG PET CT; Thyroid

Indexed keywords

ESTROGEN RECEPTOR; FLUORODEOXYGLUCOSE F 18; LIOTHYRONINE; PROGESTERONE RECEPTOR; THYROTROPIN; THYROXINE;

ARTICLE; BREAST CARCINOMA; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; THYROID FUNCTION TEST; THYROID GLAND; ULTRASOUND;

EID: 74849118857     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2009.12.4.309     Document Type: Article

References (17)

1. KIM TS, Moon WK, Lee DS. FDG-PET for the detection of recurrent or metastatic breast cancer. J Korean Breast Cancer Soc 2000;3:25-33.
2. Noh DY, Yun IJ, Kang HS, Kim JS, Lee DS, Chung JK, et al. The diagnostic value of positron emission tomography in detecting the breast cancer. J Korean Breast Cancer Soc 1998;1:6-12.
3. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008;49:480-508.
4. Field J. Intermediary metabolism of the thyroid. In: Astwood EB, Greep RO, editors. American Physiological Society Handbook of Physiology: Endocrinology-Section 7, Volume III, Thyroid. Washington, DC: American Physiological Society; 1974. p.147-59.
5. Hosaka Y, Tawata M, Kurihara A, Ohtaka M, Endo T, Onaya T. The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology 1992;131:159-65.
6. Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman MM, Wahl RL. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 2005;234:879-85.
7. Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, et al. Clinical significance of diffusely increased F-18 FDG uptake in the thyroid gland. J Nucl Med 2007;48:896-901.
8. Kurata S, Ishibashi M, Hiromatsu Y, Kaida H, Miyake I, Uchida M, et al. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis. Ann Nucl Med 2007;21:325-30.
9. 18F-fluorodeoxyglucose positron emission tomography. Biomed Pharmacother 2007;61:488-93.
10. Liu Y. Clinical significance of thyroid uptake on F-18 fluorodeoxyglucose positron emission tomography. Ann Nucl Med 2009;23:17-23.
11. Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y, et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998;207:775-8.
12. Chen YK, Chen YL, Cheng RH, Yeh CL, Lee CC, Hsu CH. The significance of FDG uptake in bilateral thyroid glands. Nucl Med Commun 2007;28:117-22.
13. Giani C, Fierabracci P, Bonacci R, Gigliotti A, Campani D, De Negri F, et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 1996;81:990-4.
14. Giustarini E, Pinchera A, Fierabracci P, Roncella M, Fustaino L, Mammoli C, et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 2006;154:645-9.
15. Tateishi U, Gamez C, Dawood S, Yeung HW, Cristofanilli M, Inoue T, et al. Chronic thyroiditis in patients with advanced breast carcinoma: metabolic and morphologic changes on PET-CT. Eur J Nucl Med Mol Imaging 2009;36:894-902.
16. Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005;115:1074-8.
17. Wolf G, Aigner RM, Schaffler G, Schwarz T, Krippl P. Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland. Nucl Med Commun 2003;24:1225-30.